Abstract
Embryonic stem cells (ESCs) have the capacity for self-renewal and pluripotency. Due to high proliferative activity, ESCs use a specific pathway of the formation of ATP molecules, which can lead to the development of the adaptive metabolic response under the conditions of energy deficiency (which is different from the response of differentiated cells). It is known that metabolic signals are integrated with the cell cycle progression; however, the signaling pathways that connect the availability of nutrients with the regulation of cell cycle in ESCs are insufficiently studied. We have studied the effect of the AICAR agent, which imitates an increase in AMP level and induces the activation of the metabolic sensor AMPK, on proliferation, cell cycle distribution, and pluripotency of mouse ESCs (mESCs). It has been demonstrated that cells treated with AICAR do not stop at the control G1/S point of the cell cycle, since they do not accumulate P21/WAF1 (G1/S checkpoint regulator), despite P53 activation. On the contrary, AICAR increases the rate of mESC proliferation, which correlates with increased expression of pluripotency marker genes (OCT3/4, NANOG, SOX2, KLF4, ESRRB, PRDM14). In addition, an increase in the transcription of the HIF1α gene (a key regulator of the cell proliferation and viability, as well as glucose metabolism under stress) was detected. An increase in the expression of glycolytic enzyme genes (LDHA, ALDOA, PCK2, GLUT4) under the effect of AICAR indicates a change in mESC metabolism towards increased glycolysis. Thus, AICAR-dependent AMPK activation as one of possible mechanisms of the mESC adaptive response to the emergence of energetic imbalance is not accompanied by a cell cycle arrest at the G1/S checkpoint, but involves the processes of increasing glycolytic activity.
Similar content being viewed by others
Abbreviations
- AICAR:
-
5-aminoimidazole-4-carboxamide ribonucleotide
- AMPK:
-
AMP-activated protein kinase
- LDHA:
-
lactate dehydrogenase A
- ALDOA:
-
aldolase A
- PCK2:
-
phosphoenolpyruvate carboxykinase 2
- GLUT4 and GLUT1:
-
glucose transporter types 4 and 1
- RA:
-
retinoic acid
References
Malashicheva A.B., Kisliakova T.V., Pospelov V.A. 2002. Embryonal stem cells do not undergo cell cycle arrest upon exposure to damaging factors. Tsitologiya. 44, 649–655.
Chuykin I.A., Lianguzova M.S., Pospelova T.V., Pospelov V.A. 2008. Activation of DNA damage response signaling in mouse embryonic stem cells. Cell Cycle. 7, 2922–2928.
Becker K.A., Ghule P.N., Therrien J.A., et al. 2006. Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. J. Cell. Physiol. 209, 883–893.
Suvorova I.I., Katolikova N.V., Pospelov V.A. 2012. New insights into cell cycle regulation and DNA damage response in embryonic stem cells. Int. Rev. Cell. Mol. Biol. 299, 161–198.
Prigione A., Adjaye J. 2010. Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells. Int. J. Dev. Biol. 54, 1729–1741.
Varum S., Rodrigues A.S., Moura M.B., et al. 2011. Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS One. 6, e20914.
Folmes C.D., Nelson T.J., Martinez-Fernandez A., et al. 2011. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell. Metab. 14, 264–271.
Zhang J., Khvorostov I., Hong J.S., et al. 2011. UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells. EMBO J. 30, 4860–4873.
Warburg O. 1956. On the origin of cancer cells. Science. 123, 309–314.
Gardner D.K. 2015. Lactate production by the mammalian blastocyst: Manipulating the microenvironment for uterine implantation and invasion? Bioessays. 37, 364–371.
Wu M., Neilson A., Swift A.L., et al. 2007. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am. J. Physiol.: Cell Physiol. 292, 125–136.
Facucho-Oliveira J.M., Alderson J., Spikings E.C., et al. 2007. Mitochondrial DNA replication during differentiation of murine embryonic stem cells. J. Cell Sci. 120, 4025–4034.
Todd L.R., Damin M.N., Gomathinayagam R., et al. 2010. Growth factor erv1-like modulates Drp1 to preserve mitochondrial dynamics and function in mouse embryonic stem cells. Mol. Biol. Cell. 21, 1225–1236.
Mandal S., Lindgren A.G., Srivastava A.S., et al. 2011. Mitochondrial function controls proliferation and early differentiation potential of embryonic stem cells. Stem Cells. 29, 486–495.
Rafalski V.A., Mancini E., Brunet A. 2012. Energy metabolism and energy-sensing pathways in mammalian embryonic and adult stem cell fate. J. Cell. Sci. 125, 5597–608.
Cherepkova M.Y., Sineva G.S., Pospelov V.A. 2016. Leukemia inhibitory factor (LIF) withdrawal activates mTOR signaling pathway in mouse embryonic stem cells through the MEK/ERK/TSC2 pathway. Cell Death Dis. 14, e2050.
Chen H., Liu X., Chen H., et al. 2014. Role of SIRT1 and AMPK in mesenchymal stem cells differentiation. Ageing Res. Rev. 13, 55–64.
Qu J., Lu D., Guo H., et al. 2016. MicroRNA-9 regulates osteoblast differentiation and angiogenesis via the AMPK signaling pathway. Mol. Cell. Biochem. 411, 23–33.
Jones R.G., Plas D.R., Kubek S., et al. 2005. AMPactivated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell. 18, 283–293.
Dasgupta B., Milbrandt J. 2009. AMP-activated protein kinase phosphorylates retinoblastoma protein to control mammalian brain development. Dev. Cell. 16, 256–270.
Imamura K., Ogura T., Kishimoto A., et al. 2001. Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochem. Biophys. Res. Commun. 287, 562–567.
Zang Y., Yu L.F., Nan F.J., et al. 2009. AMP-activated protein kinase is involved in neural stem cell growth suppression and cell cycle arrest by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and glucose deprivation by down-regulating phospho-retinoblastoma protein and cyclin D. Biol. Chem. 284, 6175–6184.
Rattan R., Giri S., Singh A.K., Singh I. 2005. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase. J. Biol. Chem. 280, 39582–39593.
Liang X., Wang P., Gao Q., Tao X. 2014. Exogenous activation of LKB1/AMPK signaling induces G1 arrest in cells with endogenous LKB1 expression. Mol. Med. Rep. 9, 1019–1024.
Teng H., Sui X., Zhou C., et al. 2016. Fatty acid degradation plays an essential role in proliferation of mouse female primordial germ cells via the p53-dependent cell cycle regulation. Cell Cycle. 15, 425–431.
Cai X., Hu X., Tan X., et al. 2015. Metformin induced AMPK activation, G0/G1 phase cell cycle arrest and the inhibition of growth of esophageal squamous cell carcinomas in vitro and in vivo. PLoS One. 10, e0133349.
van Meerloo J., Kaspers G., Cloos J. 2011. Cell sensitivity assays: The MTT assay. Meth. Mol. Biol. 731, 237–245.
Vallier L. 2015. Cell cycle rules pluripotency. Cell Stem Cell. 17, 131–132.
Wu S.B., Wei Y.H. 2012. AMPK-mediated increase of glycolysis as an adaptive response to oxidative stress in human cells: implication of the cell survival in mitochondrial diseases. Biochim. Biophys. Acta. 182, 233–247.
Shestov A.A., Mancuso A., Leeper D.B., Glickson J.D. 2013. Metabolic network analysis of DB1 melanoma cells: How much energy is derived from aerobic glycolysis? Adv. Exp. Med. Biol. 765, 265–271.
Schuster S., Boley D., Möller P., et al. 2015. Mathematical models for explaining the Warburg effect: A review focussed on ATP and biomass production. Biochem. Soc. Trans. 43, 1187–1194.
Watford M., Hod Y., Chiao Y.B., et al. 1981. The unique role of the kidney in gluconeogenesis in the chicken. The significance of a cytosolic form of phosphoenolpyruvate carboxykinase. J. Biol. Chem. 256, 10023–10027.
Leithner K., Hrzenjak A., Trötzmüller M., et al. 2015. PCK2 activation mediates an adaptive response to glucose depletion in lung cancer. Oncogene. 34, 1044–1050.
Zhou W., Choi C., Margineantu D., et al. 2012. HIF1α induced switch from bivalent to exclusively glycolytic metabolism during ESC-EpiSC transition. EMBO J. 31, 2103–2116.
Lu H., Forbes R.A., Verma A. 2002. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J. Biol. Chem. 277, 23111–23115.
Vazquez-Martin A., Vellon L., Quirós P.M., et al. 2012. Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells. Cell Cycle. 11, 974–989.
Suvorova I.I., Grigorash B.B., Chuykin I.A., Pospelova T.V., Pospelov V.A. 2016. G1 checkpoint is compromised in mouse ESCs due to functional uncoupling of p53-p21Waf1 signaling. Cell Cycle. 15, 52–63.
Suvorova I.I., Pospelov V.A. 2014. Analysis of irradiation-induced repair foci in mouse embryonic stem cells. Tsitologiya. 56, 340–345.
Jang H., Kim Tae W., Yoon S., et al. 2012. O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network. Cell Stem Cell. 11, 62–74.
Panopoulos A.D., Yanes O., Ruiz S., et al. 2012. The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming. Cell Res. 22, 168–177.
Mathieu J., Zhou W., Xing Y., et al. 2014. Hypoxiainducible factors have distinct and stage-specific roles during reprogramming of human cells to pluripotency. Cell Stem Cell. 14, 592–605.
Kim H., Jang H., Kim T.W., et al. 2015. Core pluripotency factors directly regulate metabolism in embryonic stem cell to maintain pluripotency. Stem Cells. 33, 2699–2711.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © B.B. Grigorash, I.I. Suvorova, V.A. Pospelov, 2018, published in Molekulyarnaya Biologiya, 2018, Vol. 52, No. 3, pp. 489–500.
Rights and permissions
About this article
Cite this article
Grigorash, B.B., Suvorova, I.I. & Pospelov, V.A. AICAR-Dependent Activation of AMPK Kinase Is Not Accompanied by G1/S Block in Mouse Embryonic Stem Cells. Mol Biol 52, 419–429 (2018). https://doi.org/10.1134/S0026893318030056
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893318030056